【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q2 2013 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q2 2013 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q2 2013 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q2 2013 19
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q2 2013 20
2.4.1 Life Technologies Receives Shareholders Approval for Its Acquisition by Thermo Fisher Scientific for US$13.6 Billion 20
2.4.2 Valeant Pharma Completes Acquisition of Bausch & Lomb for US$ 8.7 Billion 22
2.4.3 Actavis Receives French Competition Authority Approval to Acquire Warner Chilcott for US$8.5 Billion 23
2.4.4 Merck Completes Public Offering of Notes for US$6.5 Billion 24
2.4.5 Tenet Healthcare to Acquire Vanguard Health Systems for US$4.3 Billion 25
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 26
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q2 2013 26
3.1.1 Top M&A Deals in Q2 2013 28
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q2 2012 – Q2 2013 29
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q2 2013 31
3.2.1 Top Initial Public Offerings in Q2 2013 32
3.2.2 Top Secondary Offerings in Q2 2013 32
3.2.3 Top PIPE Deals in Q2 2013 33
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q2 2012-Q2 2013 33
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q2 2012 – Q2 2013 34
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q2 2013 36
3.3.1 Top Venture Financing Deals in Q2 2013 37
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2013 38
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2013 39
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q2 2012 – Q2 2013 40
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 42
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 44
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q2 2013 45
3.4.1 Top Private Equity Deals in Q2 2013 46
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q2 2012 – Q2 2013 47
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2013 49
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2013 49
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q2 2012 – Q2 2013 51
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2013 53
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q2 2013 54
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2013 55
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q2 2013 56
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 57
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q2 2012 – Q2 2013 59
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q2 2012 – Q2 2013 60
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 62
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q2 2013 64
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q2 2013 64
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 66
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q2 2013 68
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q2 2013 68
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q2 2013 69
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q2 2012 – Q2 2013 70
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q2 2012 – Q2 2013 72
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2012 – Q2 2013 74
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2012 – Q2 2013 75
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q2 2012 – Q2 2013 77
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 79
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q2 2012 – Q2 2013 79
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q2 2012 – Q2 2013 81
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q2 2012 – Q2 2013 83
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q2 2012 – Q2 2013 85
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q2 2012 – Q2 2013 87
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q2 2012 – Q2 2013 89
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q2 2012 – Q2 2013 90
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 92
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q2 2013 92
7.1.1 Oncology – Deals of the Quarter 94
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q2 2013 96
7.2.1 Central Nervous System – Deals of the Quarter 98
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q2 2013 99
7.3.1 Infectious Disease – Deals of the Quarter 101
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q2 2013 103
7.4.1 Immunology – Deals of the Quarter 105
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q2 2013 106
7.5.1 Metabolic Disorders – Deals of the Quarter 108
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q2 2013 110
7.6.1 Cardiovascular – Deals of the Quarter 112
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q2 2013 114
7.7.1 Gastrointestinal – Deals of the Quarter 116
7.8 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q2 2013 117
7.8.1 Ophthalmology – Deals of the Quarter 119
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q2 2013 120
7.9.1 Respiratory – Deals of the Quarter 122
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q2 2013 124
7.10.1 Dermatology – Deals of the Quarter 126
8 Deal Summary by Geography 127
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q2 2013 127
8.1.1 North America – Deals of the Quarter 129
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q2 2013 132
8.2.1 Europe – Deals of the Quarter 134
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q2 2013 136
8.3.1 Asia-Pacific – Deals of the Quarter 138
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q2 2013 139
8.4.1 Rest of the World – Deals of the Quarter 141
9 Pharmaceuticals & Healthcare, Global, Top Advisors 143
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 143
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 145
10 Appendix 147
11 Further Information 151
11.1 Methodology 151
11.2 About GlobalData 152
11.3 Disclosure information 153
11.4 Disclaimer 153
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q2 2013■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
■ 発行日：2013年8月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161917
■ 調査対象地域：グローバル
- チゴゲニンの世界市場2015Tigogenin (CAS 77-60-1) Market Research Report 2015 aims at providing comprehensive data on Tigogenin market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Tigogenin description, covers its application areas, manufacturing methods, patterns. It captures Tigogenin market trends, pays close attention to Tigogenin manufacturers and names suppliers. Besid …
- リン酸肥料のグローバル市場（～2019）The industry report Global Phosphatic Fertilizer Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for phosphatic fertilizers in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, market …
- 日本の癌診断・検査市場2014This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth, and Major Suppliers' Market SharesList of TablesTest Volume Forecasts by Market Segment …
- PT（プロトロンビン時間）検査市場：米国、ヨーロッパ、日本The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and PT testing specifically, will become more standardized, offering opportun …
- フォトニック集積回路（IC）の世界市場分析：コンポーネント別（レーザー、MUX / DEMUX、光増幅器、変調器、減衰器、および検出器）、集積別（モノリシック、ハイブリッド、およびモジュール）、原材料別（インジウム・リン、シリコン・オン・シリコン、シリコン、ガリウムヒ素その他）、用途別（光通信、センシング、バイオフォトニクス、光信号処理）、セグメント予測The photonic IC market is expected to reach USD 3.54 billion by 2024 according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired tr …
- グーグル対サービスプロバイダー（Google vs. Incumbent Service Providers）Arguably, much of Google's innovation has recently come through continuous through an aggressive acquisition strategy. The acquisition strategy has helped Google to expand in different business directions like different forms of advertising, location-based services, social media, mobile technologies, cloud business and many more. The impact of Google's expansion into non-traditional areas is begin …
- ヒストンデアセチラーゼ阻害剤市場及びパイプライン分析Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining stead …
- 人工内耳（蝸牛インプラント）の世界市場2016-2020About Cochlear Implants A cochlear implant is a surgically implanted complex electronic device that helps overcome complications in the inner ear or cochlea. This implant consists of two major components: an external component known as the sound processor and an internal component known as the implant. The sound processor receives sound waves and processes them into detailed digital information. T …
- 世界の栄養ドリンク（Energy Drink）市場動向（2014～2018）TechNavio's analysts forecast the Global Energy Drink market to grow at a CAGR of 13.38 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing brand awareness among consumers. The Global Energy Drink market has also been witnessing the increasing use of natural ingredients in energy drinks. However, the stringent government regulations could …
- タービン発電機の世界市場About Turbo Generators A turbo generator is a mechanical device that is used to produce electrical power. A turbine is connected to the turbo generator and produces electricity by converting mechanical energy into electrical energy. The steam-powered turbo generators supply most of the world's electrical power. Turbo generators are also used in other renewable power plants such as geothermal plant …
- 血小板凝集デバイスの世界市場：装置、試薬、消耗品、付属品The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) hold large shares in the global platelet aggregation devices market, and the North American region (particularly the U.S.) is expected to grow at the …
- 世界の六方晶窒化ホウ素市場2015The Global Hexagonal Boron Nitride Industry Report 2015 is a professional and in-depth study on the current state of the Hexagonal Boron Nitride industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hexagonal Boron Nitride market analyses is provided for the international markets including development t …
- 世界のアイスクリーム市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global ice cream market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global ice cream market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global ice …
- 腹腔鏡装置の世界市場2019-2023127 pages, November 2018 About this market The increasing popularity of minimally invasive procedures in the healthcare sector had led the laparoscopic devices industry grow during our forecasted period. The leading healthcare providers are encouraging the shift from conventional open surgeries towards MI surgeries, as these are less painful and allow faster recovery for the patients to return hom …
- 食品用潤滑油の世界市場：無機物、合成品（PAO/PAG）、バイオThe global market size of food grade lubricants is projected to reach 64.45 kilotons by 2021, registering a CAGR of 6.7% between 2016 and 2021. In terms of value, the market size for food grade lubricants was USD 182.8 Million in 2016, and is projected to reach USD 256.5 Million by 2021, registering a CAGR of 7.0% during the same period. The growing processed food industry i is expected to generat …
